Nanog is a novel pluripotential cell-specific gene that plays a crucial role in maintaining the undifferentiated state of early postimplantation embryos and embryonic stem (ES) cells. We have explored the expression pattern and function of Nanog and a Nanog-homologue, Nanog-ps1.Nanog-ps1 was mapped on Chromosome 7 and shown to be a pseudogene. Immunocytochemical analysis in vivo showed that the NANOG protein was absent in unfertilized oocytes, and was detected in cells of morula-stage embryos, the inner cell mass of blastocysts and the epiblast of E6.5 and E7.5 embryos, but not in primordial germ cells of early postimplantation embryos. In monkey and human ES cells, NANOG expression was restricted to undifferentiated cells. Furthermore, reactivation of the somatic cell-derived Nanog was tightly linked with nuclear reprogramming induced by cell hybridization with ES cells and by nuclear transplantation into enucleated oocytes. Notably, mouse Nanog (C/K) ES cells, which produced approximately half the amount of NANOG produced by wild-type ES cells, readily differentiated to multi-lineage cells in culture medium including LIF. The labile undifferentiated state was fully rescued by constitutive expression of exogenous Nanog. Thus, the activity of Nanog is tightly correlated with an undifferentiated state of cells even in nuclear reprogrammed somatic cells. Nanog may function as a key regulator for sustaining pluripotency in a dose-dependent manner. q
Introduction
Pluripotential competence, which is defined by the ability to generate all types of specialized tissues including germ cells, is transiently possessed by cells of preimplantation embryos and disappears soon after implantation in mammalian development. Embryonic stem (ES) cells are a type of pluripotential cells isolated under in vitro culture conditions from the inner cell mass (ICM) cells of the blastocyst. ES cells display robust capability of self-renewal with pluripotency. Another type of pluripotential stem cell is embryonic germ (EG) cells established from primordial germ cells (PGCs) isolated either while they are migrating or shortly after entry into the gonads (Matsui et al., 1992; Resnick et al., 1992) . Remarkably, ES and EG cells maintain a common capacity to reprogram somatic nuclei through the action of transacting factors upon cell hybridization with somatic cells (Tada et al., 1997 . It is notable, however, that the somatic cell-derived memory of genomic imprints is erased in EG hybrid cells but is maintained in ES hybrid cells (Tada et al., 1997 (Tada et al., , 1998 . Thus, the nuclear reprogramming activity found in ES cells may be at least partially similar to that present when mammalian cloned embryos are created using the technique of nuclear transplantation of somatic cells into enucleated unfertilized eggs (Solter, 2000) . The successful establishment of human ES cells (Amit et al., 2000; Thomson et al., 1998) and EG cells (Shamblott et al., 1998) has increased the importance of studies of these cells in the areas of not only basic stem cell research but also clinical medicine. It is hoped that stem cell-mediated tissue generation will be useful in the replacement of damaged tissues and in pharmaceutical applications.
The Oct4 gene, which is a member of the mammalian POU family of transcriptional factors, functions as a key regulator of the pluripotential state (Nichols et al., 1998; Niwa et al., 2000) . Sox2, known to act cooperatively at promoters with Oct4, transcriptionally activates the Utf1 and Fgf-4 genes (Yuan et al., 1995; Fukushima et al., 1999) . Another key molecule involved in the signaling pathway for maintaining the capacity for self-renewal and pluripotency of mouse ES cells is leukemia inhibitory factor (LIF) (Smith et al., 1988; Williams et al., 1988) . LIF directs activation of the transcriptional factor STAT3 by phosphorylation through binding to the heterodimer of LIF receptor and gp130 (Davis et al., 1993 ). An additional signal provided by bone morphogenetic proteins (BMPs) is required and induces activation of the inhibitor of differentiation (Id) genes, which repress differentiation into the neuroectodermal lineage (Ying et al., 2003) . In addition to the roles of those genes, it has been demonstrated that Ezh2 plays an important role in maintaining pluripotency of the inner cell mass cells of blastocysts and ES cells through histone H3 lysine 27 methylation-based repression of specific homeotic genes (Czermin et al., 2002; Erhardt et al., 2003; Kuzmichev et al., 2002) . Null mutations of the Oct4, Sox2, and Ezh2 genes result in embryonic lethality at implantation (Nichols et al., 1998; O'Carroll et al., 2001; Avilion et al., 2003) , while interestingly, loss of the Bmp4, Lif, Lif receptor and Stat3 genes induces no obvious defect, at least in mouse preimplantation development (Stewart et al., 1992; Li et al., 1995; Winnier et al., 1995) . It is known that LIF is dispensable for supporting self-renewal and pluripotency of monkey and human ES cells (Thomson et al., 1998) .
NANOG is a newly identified homeodomain-bearing protein, that may act as a transcriptional factor and is transcribed specifically in mouse pluripotential cells, ES cells and EG cells (Mitsui et al., 2003; Chambers et al., 2003; Wang et al., 2003; Hart et al., 2004) . The loss of epiblasts in Nanog-null embryos soon after implantation and differentiation in Nanog-deficient ES cells (Mitsui et al., 2003) and also Nanog overexpression-dependent clonal expansion of ES cells via the bypassing of regulation by LIF-STAT3 signals and OCT4 levels indicate that Nanog is an important regulator for maintaining the capacity for pluripotency and self-renewal of ES cells and early embryonic cells. However, Nanog function and expression have not been fully characterized yet.
In this study, we isolated mouse Nanog and its homologue Nanog-ps1, which is characterized by a unique intron-less genomic structure and high conservation of the DNA sequence of the coding region compared to that of Nanog. Nanog-ps1 was detected in the 129, C3H and JF1 strains but not in the C57BL/6 strain. The lack of detectable transcription of Nanog-ps1 indicated that Nanog-ps1 is a pseudogene. Immunohistochemical analysis of Nanog protein showed that maternal NANOG was undetectable in unfertilized eggs and zygotic NANOG was detected at the morula stage. Nuclei of morulae and ICM cells of blastocysts and the epiblasts of E6.5 and E7.5 embryos were positively stained. In the monkey and human, NANOG was expressed specifically in undifferentiated ES cells. Furthermore, reactivation of the somatic cell-derived Nanog was tightly linked with nuclear reprogramming induced by cell hybridization with ES cells and by nuclear transplantation into enucleated unfertilized oocytes. Remarkably, mouse Nanog (C/K) ES cells, which produced approximately half the amount of NANOG produced by wild-type ES cells, readily differentiated to multi-lineage cells in the presence of LIF. The normal phenotype was fully restored by exogenous NANOG expression.
Results

Genomic structure and expression of Nanog and Nanog-ps1
To analyze the genomic structure of the Nanog gene, a genomic library derived from mouse strain 129 was screened with a probe containing the homeodomain. We isolated two types of genomic clones. One contained four exons (Nanog), while the other had no intron and a single exon (Nanog-ps1) (accession no. we submitted) (Fig. 1A) . The DNA sequence of the open reading frame (ORF) was highly conserved (99%) between them. Nanog was mapped on Chromosome 6, as shown in the database (accession no.: NT_094510). Southern blot hybridization (Fig. 1C) , genomic PCR with an intron-specific primer (Fig. 1B ) and chromosome mapping (Fig. 1D ) analyses indicated that Nanog-ps1 exists as a unique allele on Chromosome 7 and differs from the Nanog-related sequences on mouse Chromosome 12 (accession no.: NT_039551) and X chromosome (accession no.: NT_039706). Next, to develop a means of distinguishing between the expression of Nanog and Nanog-ps1, their genomic sequences were compared in detail. DNA sequence polymorphisms were detected in the genomic PCR products amplified with primer sets F4-R4 and F3-R3, which were designed to hybridize within exon 4 (Fig. 1A) . The Nanog-ps1-derived F4-R4 PCR product (597 bp) was sensitive to the restriction enzyme BsaMI (yielding 414 and 183 bp products) whereas the Nanogderived counterpart (597 bp) was resistant to the digestion (data not shown). The Nanog-ps1-derived F3-R3 PCR product (518 bp) was digested to two fragments by the restriction enzyme NlaIII (172 and 346 bp) while the Nanog-derived counterpart (516 bp) was digested into three fragments (161, 173 and 182 bp) (Fig. 1E) . Thus, restriction fragment length polymorphism (RFLP) analysis of the RT-PCR products could be applied to distinguish the Nanog transcripts from the Nanog-ps1 transcripts. To determine which gene gave rise to the transcripts, RT-PCR products amplified with the F3-R3 primer set were digested with NlaIII. In all samples of ES cells, blastocysts, E7.5 embryos and genital ridges collected from E12.5 embryos, mRNA was transcribed only from Nanog, as shown by the lack of a 346-bp band specific to the Nanogps1 transcripts (Fig. 1F ). These data suggest that Nanog-ps1 exists as a pseudogene in the mouse genome. It is noteworthy that Nanog-ps1 PCR products amplified with the primer set F2-R3 were detected with genomic DNA from the 129/Sv, C3H/He and JF1/Ms strains but not from the C57BL/6 strain (data not shown). On the basis of these findings, we made antibody specific to NANOG for use in the studies described below.
Protein expression of Nanog in mouse
Polyclonal antibody against mouse NANOG was made by serial immunization of rabbits with in vitro-translated his-tagged NANOG. Northern blot hybridization analysis revealed a two-fold higher level of Nanog RNA transcript in EG cells than in ES cells ( Fig. 2A) . Consistent with this, the expression level of the NANOG protein was approximately two times higher in EG cells than in ES cells (Fig. 2B) . The NANOG expression level relative to histone H3 as a control was compared between EG and ES cells. NANOG was not detected in primary embryonic fibroblasts (PEFs). An important finding is that NANOG was detected as a ladder of bands in Western blot hybridization (Fig. 2B) , indicating that the protein was easily degraded. To examine the specificity of the anti-NANOG antibody, NIH3T3 cells, in Fig. 1 . Genomic and expression analyses of Nanog and Nanog-ps1. (A) Genomic structure of Nanog and Nanog-ps1. Arrow heads show the positions of forward (black) and reverse (blue) primers used for PCR analyses. The position of the probe for Southern blot hybridization analysis in B is located within exon 2. Gray boxes: homeodomain. B: BglII. S: SacI. (B) Southern blot hybridization analysis of Nanog and Nanog-ps1. Genomic DNA digested with BglII or SacI was hybridized with the probe in A. (C) Genomic PCR products specific to Nanog or Nanog-ps1. The Ex3F and Int3F forward primers are located in exon 3 and intron 3 of Nanog. The R2 reverse primer is in exon 4. (D) Mapping of Nanog-ps1 by fluorescence in situ hybridization. Nanog-ps1-specific signals were located at the E3 band of mouse Chromosome 7 visualized by G-band staining with DAPI. H19 cosmid probe was used as a position marker on mouse Chromosome 7. (E) DNA sequence polymorphisms between Nanog and Nanog-ps1. On the basis of sensitivity to the restriction enzyme NlaIII, the origin of the F3-R3 genomic PCR products was determined. (F) Exclusive transcription of Nanog mRNA in the mouse. Nanog-ps1-derived RT-PCR products amplified with the F3-R3 primer set were undetectable, as shown by the lack of 346-bp fragments after digestion with restriction enzyme NlaIII (see E).
which endogenous Nanog was repressed to below the limit of detection, were transfected with flag-tagged Nanog and stained with antibodies. Positive signals detected with the anti-flag antibody (green) overlapped with those detected with anti-NANOG antibody (red), indicating that our antibody specifically recognized NANOG (Fig. 2C) . To further confirm this, a mixture of ES cells and thymocytes was stained with the antibody. The anti-NANOG antibody immuno-reacted with the ES cells (red) but not with the thymocytes (Fig. 2D) . NANOG signals were localized in the nuclei of cells, as shown by colocalization with DAPIpositive signals ( Fig. 2D and E) .
In pre-implantation development of mouse embryos, no signal was found in unfertilized eggs or 2-cell-or 8-cellstage embryos, and zygotic expression of NANOG was first detected in cell nuclei of morula-stage embryos (Fig. 3) . In the blastocysts, the ICM cells were positively stained, while the trophectoderm cells were negative for the immunoreaction (Fig. 3) . In the early post-implantation development of mouse embryos, a NANOG-positive signal was found in the epiblasts of E6.5 and E7.5 embryos but not in the intra-embryonic mesoderm or extraembryonic endoderm cells. The signal disappeared in E8.5 embryos. In E7.5 embryos, the caudal region (primitive streak region) of epiblasts was prominently positive and the intensity of the positive signals gradually decreased from the proximal to the distal region of the epiblast. It is notable that PGCs, which were positive for PGC7/Stella and had colonized the region proximal to the allantoic rudiment, were negative for the antibody reaction (Fig. 3 ).
Protein expression of Nanog in primate ES cells
We determined the Nanog DNA sequences and inferred the amino acid (AA) sequences by analysis of ES cell-derived transcripts of the cynomolgus monkey Macaca fascicularis (accession no. we submitted) and mouse Mus musculus molossinus (accession no. we submitted). Replacement of two AAs at positions no. 261 and 267 was found by comparing the sequences of M. m. domesticus (accession no.: XM_132755) and M. m. molossinus (Fig. 4A ). AA sequences were highly conserved between the human and monkey (97%) but not between the mouse and primate (55%) sequences. In the homeodomain (AAs no. 97-156 in Fig. 4A ), however, nearly 90% of the AA sequence was identical between the mouse and primates, suggesting that Nanog might function as a transcriptional factor that is localized in the nucleus of pluripotential cells.
In mouse ES cells, the NANOG antibody recognized ES cell colonies but not PEFs (Fig. 4B ). Double staining with antibodies to NANOG and OCT4 revealed that the two signals were overlapping in the majority of colonies (Fig. 4B) . Notably, however, the cells positive for OCT4 were not always positive for NANOG. Out of 546 ES cells examined, 357 (65.4%) cells were positive for both OCT4 and NANOG, 189 (34.6%) cells were positive for OCT4 and negative for NANOG, and none were positive for NANOG and negative for OCT4 (Fig. 4C) . In monkey and human ES cells, the NANOG antibody specifically immuno-reacted with nuclei of ES cells but not with those of PEFs (Fig. 4B ). Similarly to mouse ES cells, the majority of ES cells were double-positive for both NANOG and OCT4, but a certain fraction of the ES cell population was positive only for OCT4.
Reactivation of Nanog by nuclear reprogramming
The requirement for Nanog for maintaining the pluripotency of cells led us to consider it likely that the somatic cell-derived Nanog would be reactivated through nuclear reprogramming for the acquisition of pluripotency. To test this, we induced nuclear reprogramming of somatic cells by cell hybridization with ES cells (Fig. 5A ) and by nuclear transplantation (NT) of somatic cells into enucleated unfertilized eggs (Fig. 5D ). In the ES hybrid cells, to determine the origin of transcripts, domesticus ES cells and molossinus thymocytes (HxJ) and vice versa (MxJ) were electrically fused, since DNA sequence polymorphisms are often seen between the domesticus and molossinus genomes. Nanog transcripts were PCR-amplified with the primer set of F1 and R1 in domesticus and molossinus ES cells and all of the inter-subspecific hybrid clones, but not in thymocytes (Fig. 5B) . The molossinus-derived transcripts were sensitive to digestion with the restriction enzyme SnaBI and were detected as two bands at 340 and 230 bp, while the domesticus-derived transcripts were resistant to (Table 1 ) are sensitive to digestion with the restriction enzyme SnaBI, while mol-derived RT-PCR products are resistant. (D) Scheme of reconstructed egg production by nuclear transplantation of somatic cells. Somatic nuclei collected from (dom!mol)F1 fibroblast cells are transplanted into enucleated dom-derived unfertilized oocytes. (E) Re-activation of somatic cellderived Nanog in cloned blastocysts (NT). Mol-derived RT-PCR products amplified with F1-R1 primer set (Table 1 ) are sensitive to digestion with the restriction enzyme FokI, while dom-derived RT-PCR products are resistant. the digestion and were detected as a single band at 570 bp (Fig. 5C ). In all of the independent MxR and HxJ hybrid clones, both domesticus-and molossinus-derived transcripts were equivalently detected as bands at 570, 340 and 230 bp, indicating that the somatic cell-derived Nanog was reactivated through nuclear reprogramming and was transcribed as actively as the ES cell-derived Nanog. Similar results were obtained in the cloned blastocysts created by NT of (domesticus!molossinus) F1 fibroblast nuclei into enucleated domesticus oocytes (Fig. 5D ). Re-expression of Nanog was detected in NT-cloned blastocysts, as in normal blastocysts. The RT-PCR products were digested with FokI. The molossinus-derived mRNA was obviously transcribed, as revealed by the two bands at 326 and 244 bp, which were specific to the somatic molossinus genome (Fig. 5E) . Thus, reactivation of Nanog transcription was tightly linked with acquisition of pluripotential competence of somatic genomes through nuclear reprogramming not only by NT but also by cell hybridization with ES cells.
Labile pluripotency of Nanog (C/K) ES cells
To explore the function of Nanog in regulating the stability of pluripotency and self-renewal of cells, the Nanog allele was disrupted by homologous recombination in R1 ES cells. A targeting vector was constructed with the 2.5-kb genomic fragment upstream of the 5 0 end of the ORF and the 3.9-kb genomic fragment downstream of the 3 0 end of the ORF (Fig. 6A) . The full ORF of Nanog was replaced with a GFP-IRES-puro-pA reporter and selection cassette in the targeted allele. Southern blot hybridization analysis clearly indicated that homologous recombination took place in two out of 11 clones examined. The targeted DNA fragment was detected as a 4.0-kb band by hybridization of the BamHIdigested genomic DNA with the 5 0 probe and as a 5.6-kb band by hybridization of the XbaI-and NcoI-digested genomic DNA with the 3 0 probe (Fig. 6B) . Northern blot hybridization analysis with a full-length Nanog cDNA probe revealed that disruption of one of the two alleles resulted in expression of half the amount of Nanog transcripts in ES cells heterozygous for the null mutation (ES (C/K) cells) compared to wild-type ES cells. This was confirmed by Western blot hybridization analysis (Fig. 6C) in which approximately half the amount of NANOG protein was detected in the ES (C/K) cells compared to wild-type ES cells, indicating that one of the two alleles was completely inert. Consequently, undifferentiated ES (C/K) cells were visualized as GFP-positive cells, while differentiated ES (C/K) cells obtained in vitro by a 3-day adhesion culture without LIF or feeder cells following a 5-day suspension culture for making embryoid bodies were negative for GFP (Fig. 6D) . Thus, expression of the GFP reporter gene was controlled by the endogenous transcription regulatory elements and consequently the GFP signals were localized specifically in cells in a pluripotential state. Chimeric mice were successfully made by re-introduction of the ES (C/K) cells into the blastocoel cavity of blastocysts.
In contrast with the original wild-type R1 ES cells, the ES (C/K) cell colonies were labile with regard to maintaining pluripotency. Re-cloning of undifferentiated cell populations was not effective for rescuing the stability of pluripotency. To keep the ES (C/K) cells undifferentiated, frequent subculturing was required even in the presence of LIF and PEF feeder cells. The phenotype of R1 and ES (C /K) cells, which were cultured in the presence of LIF and in the absence of feeder cells for 3 days following a 4-day culture on feeder cells in the presence of LIF without passage, is shown in Fig. 6E . The majority of the ES (C/K) cells were differentiated, as shown by the lack of expression of GFP, whereas the R1 cells were undifferentiated, indicating that half the normal amount of NANOG per cell was not sufficient to maintain an undifferentiated state. To specify the cell type of ES (C/K) cell derivatives, transcription of several marker genes was examined by RT-PCR analysis. In the differentiated ES (C/K) cells, transcription of pluripotential state-specific Nanog and Oct4 decreased drastically, while transcription of differentiated cell-specific genes such as the endoderm markers Gata4, TM and Bmp2, the trophoectoderm marker Cdx2, the mesoderm markers T and Hand1 and the ectodermal marker Fgf5 was significantly upregulated (Fig. 6F) . To examine whether the defective phenotype of ES (C/K) cells was normalized by expression of the exogenous NANOG, the pCAG-Nanog (molossinus) ORF-pA construct was cotransfected with the selection marker gene of Pgk-neo. The undifferentiated state of the rescued ES cells was stably maintained without feeder cells in the presence of LIF in all four independent clones obtained ( Fig. 6G) . RT-PCR products of the exogenous Nanog ORF transcripts were digested with the restriction enzyme BsmI. The endogenous domesticus-derived Nanog was sensitive but the exogenous molossinus-derived Nanog was resistant to the digestion. The expression level of NANOG was approximately two-fold in TG1 and 1.5-fold higher in TG2 than in the wild-type ES cells. Thus, the amount of NANOG per cell is crucial for stably maintaining an undifferentiated state even in the presence of LIF.
Discussion
Nanog has been reported to be a key gene for maintaining pluripotentiality, as defined by the capacity for multilineage differentiation and perpetual self-renewal (Mitsui et al., 2003; Chambers et al., 2003) . Here we identified a Nanog homologue, Nanog-ps1, on mouse Chromosome 7. Nanog-ps1, characterized by an intron-less gene structure, was determined to be a pseudogene based on its lack of detectable transcription in various embryonic tissues and ES cells. Immunostaining with antibody against NANOG clearly indicated that NANOG was localized in the nuclei of cells and was expressed in morula-stage embryos, the ICM cells of blastocysts and the epiblasts of E6.5 and E7.5 embryos. Similarly to mouse ES cells, monkey and human undifferentiated ES cells positively immuno-reacted with the NANOG antibody. Nuclear reprogramming of somatic nuclei by cell hybridization with ES cells or NT to unfertilized oocytes induced reactivation of the somatic cell-derived Nanog in association with reactivation of Oct4. The deletion of one of the two Nanog alleles resulted in the production of only half the normal amount of NANOG per cell, resulting in a notably unstable undifferentiated state of ES cells even when they were cultured in the presence of LIF and feeder cells. The defective phenotype was fully normalized by exogenous NANOG expression. Thus, the pluripotency of ES cells depends on the level of expression of NANOG.
Nanog is transcribed in morula-stage embryos, the ICM of blastocysts and the epiblast of E6.5 and E7.5 embryos but not in unfertilized or 2-cell-or 8-cell-stage embryos during mouse development and is also expressed in cultured ES and EG cells (Mitsui et al., 2003; Chambers et al., 2003; Wang et al., 2003; Hart et al., 2004 ; this study). Null-mutation of Nanog triggers the differentiation of ES cells in vitro and results in embryonic lethality due to a lack of epiblast formation in E5.5 embryos in vivo (Mitsui et al., 2003) . Furthermore, a rather high level of exogenous Nanog expression is sufficient for colonization and expansion of ES cells independent of the signaling pathway of the transcriptional factor STAT3 and of the maintenance of the OCT4 level . More recently, it was shown that BMPs act in combination with LIF to sustain the properties of pluripotential cells under serum-and feeder cell-free culture conditions (Ying et al., 2003) . However, Nanog overexpression experiments clearly indicated that NANOG renders both BMPs and serum stimulation redundant via constitutive activation of Id genes (Ying et al., 2003) . Therefore, it has been believed that Nanog plays a crucial role in maintaining the pluripotential properties of ES cells but that it acts independently of the LIF/Stat3, BMP/ Smad and Oct4/Sox2 pathways. Consistent with this, the expression pattern of NANOG was not identical to that of OCT4 in mouse embryonic development. A strong NANOG signal was localized in the epiblast of E6.5 embryos and in the caudal region of the epiblast of E7.5 embryos. Interestingly, in E7.5 embryos, OCT4-positive PGCs, which were colonized in the region proximal to the allantois, were undetectable with the NANOG antibody. The temporally and spatially distinctive expression patterns of Nanog and Oct4 support the idea that the on-off switching of Nanog expression may be directed by a pathway independent of Oct4 or by synergistic action of Oct4 and another cofactor in vivo. However, these findings do not rule out the possibility of crosstalk with OCT4, which may be involved in enhancing Nanog expression and thus act cooperatively to maintain the pluripotency of cells.
Importantly, approximately 65% of ES cells were double-positive for NANOG and OCT4, while 35% of ES cells were positive for OCT4 (OCT4(C)) and negative for NANOG (NANOG(K)). The OCT4(C)/NANOG(K) ES cells were phenotypically indistinguishable from the OCT4(C)/NANOG(C) ES cells. Also, careful observation of the OCT4(C)/NANOG(K) ES cells revealed that the phenotype was independent of the phase of the cell cycle (data not shown). An especially interesting finding was that the NANOG protein is easily fragmented, as shown by the ladder of bands visualized by Western blot hybridization analysis (Mitsui et al., 2003; Figs. 2B and 6C) , indicating the possibility that NANOG turns over rapidly. Thus, exponentially growing undifferentiated ES cells exhibit the OCT4(C)/NANOG(C) phenotype, while cell cycle-elongated undifferentiated ES cells may be characterized by the OCT4(C)/NANOG(K) phenotype. In fact, thawed and freshly plated ES cells were negative for NANOG, but following a number of passages, the phenotype of the vigorously proliferating ES cells was changed to NANOG(C). The NANOG(C) and NANOG(K) phenotypes may thus switch over time, and the NANOG(K) phenotype marks cells in a differentiationpermissive state. Consistent with this idea, as a consequence of overexpression of exogenous Nanog, the stability of the undifferentiated state of ES cells increases . The lack of NANOG, as found in Nanog(K/K) ES cells, may be easily induced by rapid degradation of NANOG in the Nanog(C/K) ES cells even under optimal culture conditions. Thus, deletion of one of the two Nanog alleles exerts a detrimental effect on the maintenance of pluripotential properties due to the resultant insufficient amount of the NANOG protein.
The undifferentiated state of Nanog (C/K) ES cells can be maintained under adequate culture conditions in the presence of feeder cells (Mitsui et al., 2003; Chambers et al., 2003;  this study) and the expression profile of several marker genes in Nanog (C/K) ES cells was similar to that in wild-type ES cells (Mitsui et al., 2003) . However, the pluripotency of Nanog (C/K) ES cells was highly unstable under inadequate culture conditions without feeder cells (Fig. 6E ) and these ES cells had plasticity to differentiate to endodermal, mesodermal and ectodermal derivatives, as shown by transcription of the several marker genes examined (Fig. 6F) . This finding contradicts some data previously obtained in experiments with Nanog(K/K) ES cells (Mitsui et al., 2003) , namely that Nanog(K/K) ES cells dominantly expressed endoderm transcription factors, parietal endoderm markers and visceral endoderm markers but not mesoderm or ectoderm markers. One possible explanation for the conflicting findings is the difference in the deleted regions; in our case the full ORF encompassing the homeodomain was replaced by GFP-IRES-puro, while in the Nanog(K/K) ES cells the homeodomain was simply deleted. Another possible explanation is that the Nanog(K/K) ES cells spontaneously underwent differentiation, while our Nanog (C/K) ES cells were induced to differentiate under inadequate culture conditions. The most likely explanation is NANOG dose-dependent cell differentiation. The complete absence of Nanog transcripts leads to cell differentiation specific to the extraembryonic endodermal lineage, while a gradual decrease of NANOG by 0-50% may induce the generation of various types of tissues as a consequence of not only endodermal gene activation but also mesodermal and ectodermal gene activation. Recently, it was shown that BMPs function to maintain the capability of self-renewal and pluripotency through the up-regulation of Id genes that repress neuroectodermal genes and that Nanog renders BMP function redundant by causing substantial maintenance of the Id expression level (Ying et al., 2003) . This finding is consistent with the induction of ectodermal differentiation of the Nanog (C/K) ES cells under inadequate culture conditions without feeder cells. Nanog may function in a dose-dependent manner similarly to Oct4, whose upregulation causes endodermal and mesodermal differentiation, and whose down-regulation results in differentiation into trophectoderm cells (Niwa et al., 2000) . To address the function in more detail, analysis of Nanog using a quantitative expression system will be required.
Acquisition of pluripotential competence by somatic nuclei is induced by the process of nuclear reprogramming through transplantation of somatic cell nuclei into enucleated oocytes in vivo (Solter, 2000) or cell hybridization of somatic cells with ES cells in vitro (Tada et al., , 2003 . It has been hypothesized that nuclear reprogramming is achieved as a consequence of dynamic changes of epigenetic modifications leading from a somatic state to a pluripotential state . DNA methylation and posttranslational acetylation, phosphorylation and methylation of histone N-termini function to regulate transcriptional activation and repression of genes (Lachner et al., 2003) . Our recent data showed that the reprogrammed somatic genome of ES hybrid cells becomes hyper-acetylated at histone H3 and H4, while histone H3 lysine 4 (K4) becomes globally hyper-dimethylated. Interestingly, H3-K4 dimethylation of the reprogrammed somatic genomes is independent of gene activity and represents one of the major events that occur during the nuclear reprogramming towards a transcriptional activation-permissive state (Kimura et al., 2004) . Therefore, we have proposed a two-step nuclear reprogramming model: the first step is global erasure of somatic cellspecific epigenetic memory in association with chromatin decondensation, as marked by H3-K4 hyper-dimethylation, and the second step is re-establishment of a pluripotential cell-specific epigenotype, as indicated by reactivation of the somatic cell-derived Oct4 Boiani et al., 2002) , inactivated X chromosome (Eggan et al., 2000; and Nanog (Fig. 5) . Interestingly, mRNA and protein of Nanog were not detectable in unfertilized oocytes, but were found from the morula-stage onward in preimplantation development, indicating that Nanog might play a key function in establishing and maintaining a pluripotential cell-specific epigenotype but not in the initial step of the reprogramming. Key regulator(s) of Nanog and factors directed by Nanog remain to be identified. A mammalian homologue of Drosphila Pc-G Enhancer of Zeste, Ezh2, which interacts with the embryonic ectoderm development gene EED and HDAC (O'Carroll et al., 2001; Erhardt et al., 2003) are expressed in ES cells and function in repressing specific homeotic genes. Although the Nanog ORF encompasses a homeodomain, its expression is independent of the expression of Ezh2. Properly orchestrated expression of Nanog, Ezh2 and Oct4 is required for establishing a pluripotential cell-specific epigenotype, in which genes responsible for cell differentiation are silenced directly or indirectly.
Experimental procedures
ES cell lines
TMA-29 (female), HM-1 (male) and R1 (male) ES cell lines were derived from Mus musculus domesticus 129 blastocysts. The HM-1 ES cell line is deficient for the Hprt gene on the X chromosome. The MP4 ES cell line was established from a male Mus musculus molossinus blastocyst. Monkey CMK6 (Suemori et al., 2001 ) and human KhES-1 ES cell lines were established from a male cynomolgus monkey (Macaca fascicularis) and a female human blastocyst, respectively. The human ES cells were cultured according to the guidelines for derivation and utilization of human embryonic stem cells (MEXT, Japan 2001) . TMA-58G is a mouse EG cell line established from a primordial germ cell of a female E12.5 embryo (Tada et al., 1998) . The ES and EG cell lines were maintained in ES medium (DMEM; Dulbecco's modified Eagle's medium) supplemented with 15% fetal bovine serum, 10 K4 M 2-mercaptoethanol and 1000 units/ml recombinant leukaemia inhibitory factor (LIF; Chemicon) on mouse primary embryonic fibroblast (PEF) feeder cells inactivated with mitomycin C.
Genomic DNA screening
A mouse 129/Sv-derived genomic DNA library constructed in the Lambda FIX II vector (Stratagene) was amplified with the XL1-Blue MRF (P2) host strain. Approximately 5!10 5 cells were plated on agar plates and hybridized with Nanog-specific DNA probe generated by RT-PCR using the F2 and R2 primer set (Table 1) . Each positive clone was amplified and then hybridized with the probe again. The same procedure was repeated one more time. DNA collected from agarose plates was digested with SalI and SacI, and separated by electrophoresis in a 1.0% agarose gel. Each fragment was subcloned into the SacI site of pBluescript KS(K) vector.
Southern blot hybridization
Genomic DNA was digested with restriction enzyme(s), and the DNA fragments were separated by electrophoresis in a 1.0% agarose gel. The DNA was transferred to a Hybond N C filter by alkali blotting. The DNA probe was generated by RT-PCR using exon2F1 primer (5 0 -CCTCTCCTCGCCCTTCCT) and exon2R1 primer (5 0 -CTGCTTATAGCTCAGGTTCAG) (Fig. 1B) . The membrane was hybridized with probe labeled with 32 P using the Megaprime DNA labeling system (Amersham) overnight at 42 8C following pre-hybridization treatment. The membrane was washed twice in 2!SSC/ 0.1% SDS at 65 8C for 30 min and twice in 0.1!SSC/ 0.1% SDS at 65 8C for 15 min.
Northern blot hybridization
Total RNA was purified from ES and EG cells, and embryonic and adult tissues with Trizol Reagent (Gibco BRL). RNA (10 mg) was separated by electrophoresis in a 1.0% agarose gel and was transferred to a Hybond N C filter in 20!SSPE under RNase-free conditions. The membrane was hybridized with 32 P-labeled full-length Nanog cDNA as a probe. The membrane was washed twice in 2!SSC/0.1% SDS at 65 8C for 30 min and twice in 0.1!SSC/0.1% SDS at room temperature for 10 min.
Genomic PCR, RT-PCR and sequencing
PCR primers used in this study are listed in Table 1 . Genomic PCR products were amplified with LA Taq polymerase (Takara) by 30 cycles of reactions with an annealing temperature of 65 8C. For the RT-PCR of Nanog in the experiments shown in Figs. 1F and 5, cDNA was synthesized from DNaseI-treated RNA using oligo-dT primers. RT-PCR was performed with Ex or LA Taq polymerase (Takara) under the following conditions: denaturation at 94 8C for 2 min; 30 cycles of 94 8C/60 8C/ 72 8C for 30 s each; extension at 72 8C for 15 min. For the RT-PCR of tissue-specific genes in Fig. 6 , cDNA was synthesized with a random hexamer from DNaseI-treated total RNA (1 mg) in a 50-ml reaction mixture. RT-PCR products were amplified using 5 ml of the reaction mixture with an annealing temperature of 60 8C for 22-29 cycles with the indicated specific primer sets (Table 1; Niwa et al., 2000; Mitsui et al., 2003) . PCR products were visualized by electrophoresis on 1.0% agarose gels containing ethidium bromide.
For DNA sequencing, PCR products were inserted into pGEM-T Easy plasmid vector using a TA cloning Kit (Promega). The DNA sequence of clones was determined with a DNA sequencer 377 (Applied Biosystems) and a CEQ 2000XL (Beckman Coulter).
FISH mapping
Chromosome preparations from R1 ES cells were made by culturing the cells in the presence of 0.3 mg/ml colcemid for 30 min. After hypotonic treatment with 0.075 M KCl for 8 min, the cells were fixed with methanol: acetic acid (3:1) solution and air dried. Denatured chromosomes were hybridized with a probe prepared by nick translation with biotin-16-dUTP (Amersham Pharmacia) of a mixture of two genomic sequences located in the 5 0 and 3 0 regions of Nanog-ps1. Biotin was detected with streptavidin-FITC. H19 cosmid DNA was directly labeled with Cy3-dUTP. Hybridization and subsequent washes were performed as previously described (Lawrence et al., 1989) . Signals were captured and analyzed using a fluorescence microscope (Nikon) and Aquacosmos software (Hamamatsu Photonics).
Western blot hybridization
Rabbit polyclonal anti-mouse NANOG antibody was produced by immunization of the full-length NANOG protein and purification of the antibody using an affinity column. After whole-cell extracts were prepared and separated by electrophoresis on 10% SDS-polyacrylamide gels, the proteins were transferred onto a nitrocellulose membrane. The membrane was pre-hybridized for blocking treatment with 3% skim milk in PBS (phosphate-buffered saline) for 1 h at room temperature and then incubated with anti-NANOG antibodies diluted 1:1000 in blocking solution (1% BSA in PBST (0.1% Triton X-100 in PBS)) overnight at 4 8C. Following three washes in PBST, the bands were detected with alkaline phosphatase- 
conjugated secondary antibodies (Zymed) using BCIP and NBT as chromogenic substrate.
Transient expression
Nanog ORF amplified with the ORF primer set (the forward primer containing the BamHI site and the reverse primer containing the SmaI site) ( Table 1) was cloned into p3xflag-CMV10 mammalian expression vector (Sigma). NIH3T3 cells were plated in 8-well chamber slides at 1!10 4 cells per well 1 day before transfection. The p3xflag-CMV10-Nanog plasmid (1 mg) was transfected into NIH3T3 cells with Lipofectamine 2000 (Invitrogen). Cells were fixed with 3.7% formaldehyde in PBS for 10 min at room temperature 48 h after the lipofection. They were then subjected to immunocytochemistry assays.
Fluorescence immunochemistry
Mouse, monkey and human ES cells that were growing exponentially under appropriate culture conditions were fixed with 3.7% formaldehyde for 10 min and were then rinsed with PBST three times. Following pre-treatment with blocking solution (1% BSA in PBST) for 1 h, the cells were incubated with rabbit anti-NANOG polyclonal antibodies at 1:500 dilution and mouse anti-Oct4 monoclonal antibody (Santa Cruz) at 1:100 dilution for 1 h at room temperature. NIH3T3 cells that had been subjected to lipofection with p3xflag-CMV10-Nanog were treated with anti-NANOG antibody and mouse anti-flag M2 monoclonal antibody (Sigma) at 1:200 dilution. After they were rinsed with PBST three times, the cell samples were incubated with Alexa 546-conjugated goat anti-rabbit IgG antibody (Molecular Probes) at 1:500 dilution and FITC-conjugated anti-mouse IgG (Zymed) at 1:1000 dilution for 1 h. The slides were mounted with a Slow Fade Light Antifade Kit with DAPI (Molecular Probes).
Pre-and post-implantation C57BL/6J mouse embryos were fixed with 3.7% formaldehyde or 4% paraformaldehyde in PBS for 10 min at room temperature. Following blocking treatment in 1% BSA in PBST, the embryos were incubated with anti-NANOG antibody at 1:500 dilution and/or anti-PGC7/Stella antibody (Sato et al., 2002) at 1:1000 dilution for 1 h at room temperature. They were rinsed with the blocking solution four times and then incubated with Alexa 546-conjugated anti-rabbit IgG antibody (Molecular Probes) for 1 h.
Hybrid cells
Thymocytes collected from 6-to 8-week-old mice were passed through an 18-gauge needle several times and ES cells were trypsinized to make single-cell suspensions. ES cells and thymocytes were mixed at a ratio of 1:5 and washed three times in PBS. The cells were suspended in 0.3 M mannitol buffer at the concentration of 6!10 6 cells/ml. Hybrid cells were produced by electric hybridization (EZ2.5-3.0 KV/cm) using an ECM 2001 with slide glasses carrying a 1-mm electrode gap (BTX) (Tada et al., 1997) . The hybrid cell lines, HxJ-17 and 18, were obtained following 8 days of HAT (Hypoxanthine Aminopterin Thymidine) selection after electro-hybridization between domesticus HM-1 ES cells and molossinus JF1 thymocytes. Hybrid cell lines MxR-2 and 3 were obtained following 8 days of G418 selection after electrohybridization between molossinus MP4 ES cells and domesticus 129/Sv-Rosa26 thymocytes. These hybrid cells have been extensively characterized as reported previously described (Tada et al., 2003) .
Nuclear transplantation
Nuclei collected from (C57BL/6J!JF1)F1 fetus-derived fibroblast cells were transplanted into unfertilized enucleated oocytes obtained from (C57BL/6J!C3H/He)F1 females using the technique of serial nuclear transfer (Ono et al., 2001) . Total RNA collected from 30 of the cloned blastocysts was subjected to RT-PCR analysis.
4.12. Chimera production R1 ES cells (129/Sv), which are heterozygous for the deletion of Nanog ORF, were microinjected into the blastocoel cavity of blastocysts recovered from C57BL/6J female mice. The manipulated blastocysts were transferred into the uterus of pseudopregnant ICR female mice. Four out of 10 progeny were chimeric mice. One chimera had more than 50% contribution of the ES cells on the basis of coat color.
Targeted disruption of Nanog and rescue by Nanog overexpression
Targeting vector containing the 2.5-kb 5 0 -arm and the 3.9-kb 3 0 -arm was designed to replace the full Nanog ORF with the GFP-IRES-puro-pA cassette (Fig. 6A) . Linearized targeting vector (50 mg) was electroporated into 1!10 7 R1 ES cells using the condition of 250 V/500 mF with a Gene Pulser (BioRad). Genomic DNAs obtained from the puromycin-resistant clones were analyzed by Southern blot hybridization (Fig. 6B) . For rescue experiments, the linearized pCAG-Nanog(molossinus)ORF-pA vector (50 mg) was transfected into 1!10 7 Nanog (C/K) R1 (domesticus) ES cells with the linearized Pgk-neo-pA vector (5 mg). Colonies resistant to G418 selection were expanded and examined for constitutive expression of the exogenous Nanog.
